Kintor Pharma Included in MSCI China Index
- Sunday, May 15, 2022, 7:10
- PR Newswire
- Add a comment
SUZHOU, China, May 15, 2022 /PRNewswire/ — Kintor Pharmaceutical Limited (“Kintor Pharma,” HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced today that the company’s stock has been included in the MSCI China…
About the Author
admin has written 21729 stories on this site.